MedTrace Logo

The Clinical Research of Traditional Chinese Medicine Formula

NCT07746219 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-08-04

No results posted yet for this study

Summary

This study examines the efficacy and safety of Bushen Huoxue Simiao formula for tonifying the kidneys and promoting blood circulation in treating postoperative complications of upper urinary tract stones, thereby providing evidence-based medical evidence and treatment strategies for clinical practice.

Conditions

Interventions

DRUG

Bushen Huoxue Simiao Formula

Patients in this group will receive Bushen Huoxue Simiao Formula (oral Chinese herbal decoction) in addition to standard basic therapy. The dosage is one dose per day, divided into two packets, taken orally twice daily (30 minutes after breakfast and dinner). The herbal medicine is supplied by Zhejiang Sanxitang Traditional Chinese Medicine Co., Ltd.

OTHER

control group

The control group received standard treatment (postoperative anti-infective therapy, fluid replacement, hemostasis, antispasmodic and analgesic therapy, and other symptomatic treatments)

Sponsors & Collaborators

  • The Fourth Affiliated Hospital of Zhejiang University School of Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2026-08-31
Completion
2028-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07746219 on ClinicalTrials.gov